Incyte Corp (INCY)
73.13
-0.06
(-0.08%)
USD |
NASDAQ |
Jan 08, 16:00
73.13
0.00 (0.00%)
After-Hours: 20:00
Incyte Research and Development Expense (Annual): 1.628B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Exelixis Inc | 1.044B |
| Merck & Co Inc | 30.53B |
| Pfizer Inc | 10.68B |
| Biomarin Pharmaceutical Inc | 746.77M |
| Insmed Inc | 571.01M |